Shefali Agarwal
2018
In 2018, Shefali Agarwal earned a total compensation of $2M as Chief Medical Officer at Epizyme.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Non-Equity Incentive Plan | $200,500 |
| Option Awards | $1,472,846 |
| Salary | $199,615 |
| Other | $1,648 |
| Total | $1,999,609 |
Agarwal received $1.5M in option awards, accounting for 74% of the total pay in 2018.
Agarwal also received $125K in bonus, $200.5K in non-equity incentive plan, $199.6K in salary and $1.6K in other compensation.
Rankings
In 2018, Shefali Agarwal's compensation ranked 5,752nd out of 14,244 executives tracked by ExecPay. In other words, Agarwal earned more than 59.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,752 out of 14,244 | 60th |
Division Manufacturing | 2,179 out of 5,765 | 62nd |
Major group Chemicals And Allied Products | 808 out of 2,128 | 62nd |
Industry group Drugs | 675 out of 1,817 | 63rd |
Industry Pharmaceutical Preparations | 523 out of 1,391 | 62nd |
Source: SEC filing on April 18, 2019.
Agarwal's colleagues
We found four more compensation records of executives who worked with Shefali Agarwal at Epizyme in 2018.